dansylarginine n-(3-ethyl-1,5-pentanediyl)amide has been researched along with hirugen in 1 studies
Studies (dansylarginine n-(3-ethyl-1,5-pentanediyl)amide) | Trials (dansylarginine n-(3-ethyl-1,5-pentanediyl)amide) | Recent Studies (post-2010) (dansylarginine n-(3-ethyl-1,5-pentanediyl)amide) | Studies (hirugen) | Trials (hirugen) | Recent Studies (post-2010) (hirugen) |
---|---|---|---|---|---|
32 | 0 | 0 | 50 | 0 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Levine, L | 1 |
1 other study(ies) available for dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and hirugen
Article | Year |
---|---|
Alpha-thrombin and trypsin use different receptors to stimulate arachidonic acid metabolism.
Topics: Amino Acid Sequence; Animals; Arginine; Cells, Cultured; Dansyl Compounds; Epoprostenol; Hirudins; Liver; Molecular Sequence Data; Peptide Fragments; Rats; Receptor, PAR-2; Receptors, Cell Surface; Receptors, Thrombin; Thrombin; Thrombomodulin; Trypsin | 1994 |